Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Cobb Syndrome (Cutaneomenigospinal Angiomatosis)

What is Cobb Syndrome (Cutaneomenigospinal Angiomatosis)?

Cobb Syndrome, also known as Cutaneomeningospinal Angiomatosis, is a rare congenital disorder characterized by the presence of skin lesions and spinal cord deformities. The skin lesions may appear as red or purple marks, sometimes referred to as “port wine stains.” Spinal cord lesions may appear as arteriovenous malformations (AVMs), abnormal connections between arteries and veins. Hemangiomas, benign blood vessel growths, may be present in both the skin and spinal cord.  The parts of the skin and spinal cord affected are usually in the same dermatome, or area sharing common nerve connections. The spinal cord lesions can lead to neurological deficits, weakness and paralysis.

 

Synonyms

  • Cutaneomeningospinal angiomatosis
  • Spinal arteriovenous metameric syndrome
  • Cutaneous spinal angiomatosis

Cobb Syndrome, also known as Cutaneomeningospinal Angiomatosis, is a rare congenital disorder characterized by the presence of skin lesions and spinal cord deformities. The skin lesions may appear as red or purple marks, sometimes referred to as “port wine stains.” Spinal cord lesions may appear as arteriovenous malformations (AVMs), abnormal connections between arteries and veins. Hemangiomas, benign blood vessel growths, may be present in both the skin and spinal cord.  The parts of the skin and spinal cord affected are usually in the same dermatome, or area sharing common nerve connections. The spinal cord lesions can lead to neurological deficits, weakness and paralysis.

Acknowledgement of Cobb Syndrome (Cutaneomenigospinal Angiomatosis) has not been added yet.

Cobb Syndrome is extremely rare, with only about 100 cases  reported in the medical literature. Its exact prevalence is not well-documented due to its rarity, but it is estimated that less than 1 in every million people will develop Cobb Syndrome

Name Abbreviation
Cutaneomeningospinal angiomatosis
Spinal arteriovenous metameric syndrome SAMS 1-31
Cutaneous spinal angiomatosis

The exact cause of Cobb Syndrome is not known. It is believed to be due to a sporadic mutation as parents of affected children have no evidence of the disease, therefore it is not linked to genetic inheritance. The occurrence of skin and spinal cord abnormalities in the same dermatome suggest a developmental disorder affecting the vascular system.

  • Cutaneous Symptoms:

    • Red or purple “port-wine stain” birthmarks (hemangiomas) on the skin, typically present at birth or appearing early in life.

    • These lesions are usually located along the back, corresponding to the affected spinal segments.

  • Neurological Symptoms:

    • Progressive myelopathy (spinal cord dysfunction).

    • Pain in the back and legs.

    • Muscle weakness.

    • Sensory disturbances.

    • Bowel and bladder dysfunction.

    • In severe cases, paralysis.

  • Clinical Examination:

    • Observation of characteristic cutaneous hemangiomas.

    • Neurological assessment to identify spinal cord involvement.

  • Imaging:

    • Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) of the spine to visualize spinal AVMs or hemangiomas.

    • Spinal angiography to assess the vascular malformations in detail.

Diagnostic tests of Cobb Syndrome (Cutaneomenigospinal Angiomatosis) has not been added yet
  • Surgical Intervention:

    • Removal of spinal AVMs or hemangiomas to relieve spinal cord compression and prevent further neurological deterioration.

  • Endovascular Therapy:

    • Embolization (closure of blood vessels) of the AVMs to reduce blood flow and alleviate symptoms.

  • Symptomatic Management:

    • Physical therapy to maintain mobility and function.

    • Pain management through medications.

  • Laser Treatment:

    • Removal of superficial cutaneous lesions.

  • Steroid Therapy:

    • Used empirically in some cases to reduce inflammation and symptoms.

The prognosis for patients with Cobb Syndrome varies depending upon the severity and location of the spinal AVMs and the degree of neurological impairment at the time of diagnosis. Early diagnosis and appropriate treatment are crucial for better outcomes. Patients with mild symptoms may have a relatively good prognosis, while those with significant spinal cord involvement may experience more severe and lasting neurological deficits.

Tips or Suggestions of Cobb Syndrome (Cutaneomenigospinal Angiomatosis) has not been added yet.

Orphanet, Cobb Syndrome:  Cobb Syndrome.

https://www.nicklauschildrens.org/conditions/cobb-syndrome

 

Logo

Cobb Syndrome (Cutaneomenigospinal Angiomatosis) community discussions will be posted here.

There are no new discussions. Start one now!!

Community Resources
Title Description Date Link

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

This is the account for the RareShare team.


Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

Logo

Cobb Syndrome (Cutaneomenigospinal Angiomatosis) community discussions will be posted here.

There are no new discussions. Start one now!!


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.